InSightec nabs CE Mark

Focused-ultrasound developer InSightec announced that its ExAblate 2000 system has received the European CE Mark certification for pain palliation of bone metastases.

The MR-guided focused ultrasound (MRgFUS) system is currently used to treat uterine fibroids, according to the Haifa, Israel-based firm.

By staff writers
June 7, 2007

Related Reading

InSightec nets Canadian approval, March 12, 2007

InSightec nets FDA clearance for new software, March 5, 2007

FDA clears InSightec's ExAblate 2000 for GE 3T MRI, March 1, 2007

InSightec raises $15 million, August 10, 2006

InSightec to bring Exablate to Australia, Taiwan, June 21, 2006

Copyright © 2007

Page 1 of 1247
Next Page